� Kamada (TASE: KMDA), a bio-pharmaceutical company engaged in the development, fabrication and marketing of specialty life-saving therapeutics, announced that it has completed a Phase II Study with Aerosolized Alpha-1 Antitrypsin (AAT), delivered via an optimized eFlow platform nebulizer (PARI Pharma GmbH), in cystic fibrosis (CF). Preliminary results indicate that the product has an excellent condom profile; last data should be available by year-end 2008.
David Tsur, Kamada's CEO expressed satisfaction at the advancement of the company's flagship AAT product for the treatment of cystic fibrosis. "This is a major milestone for Kamada. There is significant potential for the aerosolized version of AAT, which is an innovative approach for handling of chronic inflammatory processes that could potentially prevent degeneration of lung routine. We believe that, pending the successful completion of the trials and registration process, this formulation could considerably improve the timber of liveliness and potentially extend the life expectancy of a wide mountain chain of cystic fibrosis patients."
According to Pnina Strauss, Kamada's Clinical Trials and IP Manager, "We are extremely pleased with this major achievement. Aerosolized giving medication of AAT for cystic fibrosis holds great potential for the treatment of these severely diseased patients. We ar eager to pursue the development of this product and demo the benefit for this patient population as well as other respiratory populations."
About the study
The trial run, which was a double blind, placebo controlled study was performed at the renowned Cystic Fibrosis (CF) Medical Center - Hadassah - Hebrew University Medical Center Mount Scopus in Jerusalem, Israel. The trial aimed at validatory the base hit of the product in CF patients and to assess its potential influence on lung inflammation. The results indicate an excellent safety profile of the product. Further trial details are available at hTTP://www.clinicaltrials.gov.
About Aerosolized AAT
Kamada's Aerosolized AAT, which utilizes an optimized eFlow platform nebuliser (PARI Pharma GmbH), has been designated an Orphan Drug for the handling of CF and Alpha-1 Deficiency, in both Europe and the U.S. This designation grants Kamada various benefits such as enquiry fund support, tax incentives, reduced official fees and seven to twelve days of sole distribution rights, if the company's product is first base on the market. Phase II trials in bronchiectasis are presently ongoing.
About the eFlow� Platform Nebulizer
The eFlow platform atomizer, an electronic, portable nebulizer technology political platform, enables extremely efficient aerosolization of liquid medications via a vibrating, perforated tissue layer. Compared to other spray systems, the eFlow political platform nebulizer derriere produce aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible amount of prison term. Combined with its silent mode of operation, pocket-sized size (it fits in the palm of your hand), light weight, and battery function, the eFlow platform nebulizer helps quash the core of taking daily inhaled treatments.
About PARI Pharma
PARI Pharma develops aerosol delivery devices and inhaled therapies. Based on PARI's 100-year history working with aerosols, PARI Pharma specializes in treatments for pulmonic and nasal bone administration optimized to advance delivery platforms, such as the eFlow Platform Nebulizer.
About Kamada
Kamada is a world biopharmaceutical fellowship (TASE: KMDA) developing, producing and selling a agate line of specialism life-saving biopharmaceuticals using its proprietary chromatographical purification technologies. Licensed and marketed planetary, several of these peculiarity therapeutics are currently undergoing advanced clinical trials.
http://www.kamada.com
More info
Friday, 5 September 2008
Tuesday, 26 August 2008
The Script continue to top album charts
Irish iII The Script have held on for a arcsecond week to top the album charts in Ireland and the UK with their self-titled debut.
The band have also continued to enjoy success in the UK singles chart where they have stirred up to the Number Two daub with their song 'The Man Who Can't Be Moved'.
They are being held off the Number One spot by Kate Perry, while the single cadaver at Number Three in Ireland.
The highest new ledger entry of the week in the UK charts comes from Damon Albarn's Monkey project, which debuts at five with 'Journey to The West', a "pop opera" performed entirely in Mandarin.
More info
Saturday, 16 August 2008
BioCurex Presents RECAF Results At International Cancer Congress
� BioCurex Inc. (OTCBB:BOCX) announced that the Congress Scientific Committee has recognized its presentation to the ISOBM annual meeting. BioCurex will present results obtained with its ELISA RECAF blood test for cancer at the 2008 assemblage of the International Society of Oncology and Bio-Markers (ISOBM).
The conference volition be held from October 5th to October ninth, in Tokyo, Japan and will land together scientists, clinicians and companies involved in the field of cancer markers.
Dr. Moro stated: "This year's conference is entitled, 'Development of new molecular tumor markers for diagnosing and therapy'. The subject is well chosen and critical for good reason: it reflects the penetrative need, among the scientific community as well as clinicians, for new malignant neoplastic disease markers to be secondhand in genus Cancer diagnosis and therapy. This need arises from the fact that there ar presently very few markers, their boilersuit performance is not very good and they are limited to a few types of cancer. It also reflects on the fact that since AFP and CEA were first described as cancer markers in the early 60's, not many markers get been ascertained. BioCurex has a unique cancer marker in the sense that it combines excellent performance in discriminating patients with cancer from those wHO do non have crab, along with the ability to discover very early stages of two of the most common cancers - breast and prostate gland. RECAF, our marker, too has the potential to be used on a broad spectrum of cancers, which is a fantastic advantage.
At ISOBM 2008 we'll be showing results related to the ELISA format - a type of test that nates be carried out in most research and clinical labs. We expect to elicit substantial interest among scientists to carry out collaborations that will continue to formalise, independently and through legion publications, the very adept performance of the RECAF tests."
To find more about the 2008 ISOBM meeting, go to http://isobm08.umin.jp/index.html
About BioCurex
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a crab marker known as RECAFTM, which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed licensing agreements for its cancer detection blood tests with Abbott Laboratories and with Inverness Medical Innovations (for farther information on these agreements see hither.)
The malignant neoplastic disease marker RECAFTM has emerged as a potential biomarker that crataegus laevigata be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the near common cancers, including prostate, breast, colorectal, lung and others.
To read more about BioCurex, please shoot the breeze the News section in our web site hypertext transfer protocol://www.biocurex.com.
Note
The Company has not authoritative the outlet of this information in any variant that contravenes the Communication Act and will not be creditworthy for unasked massive distribution of this material by e-mail or facsimile by unauthorized parties. Statements in this push release, which are non historical facts, are "innovative statements" inside the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are content to change at whatever time, the Company's existent results could differ materially from expected results.
BioCurex
More info
The conference volition be held from October 5th to October ninth, in Tokyo, Japan and will land together scientists, clinicians and companies involved in the field of cancer markers.
Dr. Moro stated: "This year's conference is entitled, 'Development of new molecular tumor markers for diagnosing and therapy'. The subject is well chosen and critical for good reason: it reflects the penetrative need, among the scientific community as well as clinicians, for new malignant neoplastic disease markers to be secondhand in genus Cancer diagnosis and therapy. This need arises from the fact that there ar presently very few markers, their boilersuit performance is not very good and they are limited to a few types of cancer. It also reflects on the fact that since AFP and CEA were first described as cancer markers in the early 60's, not many markers get been ascertained. BioCurex has a unique cancer marker in the sense that it combines excellent performance in discriminating patients with cancer from those wHO do non have crab, along with the ability to discover very early stages of two of the most common cancers - breast and prostate gland. RECAF, our marker, too has the potential to be used on a broad spectrum of cancers, which is a fantastic advantage.
At ISOBM 2008 we'll be showing results related to the ELISA format - a type of test that nates be carried out in most research and clinical labs. We expect to elicit substantial interest among scientists to carry out collaborations that will continue to formalise, independently and through legion publications, the very adept performance of the RECAF tests."
To find more about the 2008 ISOBM meeting, go to http://isobm08.umin.jp/index.html
About BioCurex
BioCurex, Inc. is a biotechnology company that is developing products based on patented/proprietary technology in the areas of cancer diagnosis, imaging and therapy. The technology identifies a crab marker known as RECAFTM, which is found on malignant cells from a variety of cancer types but is absent in most normal or benign cells.
BioCurex has signed licensing agreements for its cancer detection blood tests with Abbott Laboratories and with Inverness Medical Innovations (for farther information on these agreements see hither.)
The malignant neoplastic disease marker RECAFTM has emerged as a potential biomarker that crataegus laevigata be useful in the development of new cancer diagnostics tests. Preliminary studies from the investigators at BioCurex have reported a high level of clinical sensitivity and specificity for RECAF in many of the near common cancers, including prostate, breast, colorectal, lung and others.
To read more about BioCurex, please shoot the breeze the News section in our web site hypertext transfer protocol://www.biocurex.com.
Note
The Company has not authoritative the outlet of this information in any variant that contravenes the Communication Act and will not be creditworthy for unasked massive distribution of this material by e-mail or facsimile by unauthorized parties. Statements in this push release, which are non historical facts, are "innovative statements" inside the meaning given to that term in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are content to change at whatever time, the Company's existent results could differ materially from expected results.
BioCurex
More info
Thursday, 7 August 2008
Monday, 30 June 2008
Nas Drops N-Word, Delays Album
Hate him now, hear him later.
Controversial rapper Nas has announced that he is moving the release date of his highly anticipated ninth studio album back two weeks, from July 1 to July...
Wednesday, 25 June 2008
Rehearsals and parties set stage for BET Awards
LOS ANGELES —
See Also
The BET Awards buzz has begun.
With the city poised to serve as party central right through Tuesday's awards show, things were already humming around town Sunday.
At downtown's Shrine Auditorium, piles of rolled red carpet stood beside stacks of sound gear while workers bustled outside and Chris Brown, Ciara and Ne-Yo rehearsed inside.
A glitzy gift suite was stocked with watches, sneakers, bejeweled belts and blinged-out iPhone cases that awaited the arrival of A-listers.
Meanwhile, across town in West Hollywood, songwriters and producers gathered at Murano restaurant for the BMI Black Music Month brunch. Rapper Rick Ross, producer Sean Garrett and actress Regina King were among the guests who sipped champagne in honor of the artists behind the music.
Garrett gave credit to Black Entertainment Television for honoring all aspects of entertainment.
"I'm proud of BET," said the producer, who has worked with Britney Spears and Michael Jackson. "BET always gives a sense of where urban is at the moment and how they're trying to grow."
Awards-related festivities were set to continue Sunday night with a party in honor of Lil Wayne and Usher and a dinner celebrating Nelly. More events were scheduled for Monday, including a private dinner hosted by BET chief Debra Lee that was to feature a performance by Jill Scott.
The BET Awards will be broadcast live Tuesday from the Shrine at 8 p.m. EDT.
---
On the Net:
BET Awards: http://www.bet.com/specials/betawards08
See Also
Monday, 16 June 2008
Sigur Ros books quick US tour ahead of new album
Atmospheric alt-rockers Sigur Ros [ tickets ] have lined up a few US dates this month behind the forthcoming release of the band's latest studio effort.The Icelandic group, which finished a brief run of Mexican dates last week, has plotted the shows around its June 14 appearance at the Bonnaroo Festival in Manchester, TN. The mini-run will kick off tomorrow (6/11) in Omaha City, NE. Details are below.The band also has a full schedule of European dates laid out over the summer, complete details for which are posted at the Sigur Ros website.Due in stores June 23, "Med Sud i Eyrum Vid Spilum Endalaust" (English translation: "With a Buzz in Our Ears We Play Endlessly") is the band's fifth studio album, and follows 2005's "Takk...," which was certified gold in the UK and sold more than 30,000 copies in the US during its first week in stores.Despite the unwieldy title, the disc is the group's first to feature a song performed in English ("All Alright.") The album was co-produced by the band with veteran producer Flood (U2, Smashing Pumpkins) and recorded in New York City; London; the band's hometown of Reykjavik, Iceland; and Havana, Cuba.The album's track "Ara Batur," described in a press release as the "largest musical undertaking in the band's career," was recorded live in one take and features the London Sinfonietta and the London Oratory Boy's Choir, making for a total of 90 performers playing at the same time.Last year, the group released "Hvarf-Heim," a 2-CD compilation album containing studio versions of previously unreleased songs, and the live DVD "Heima," which documents the group's 2006 tour of Iceland.
Sunday, 8 June 2008
Clooney tells Cruise to mock himself
Hollywood star George Clooney has advised Tom Cruise to "make fun of himself" in order to increase his popularity.
Clooney made the comments in an interview with Time, saying that he isn't afraid to mock himself.
The actor said: "Before they could kill me on 'Batman & Robin', I said: 'It's a bad film, and I'm the worst thing in it.' You try to defend an indefensible position, you'll look like a schmuck."
"The guys I dig don't do that. Look at Winston Churchill. He said: 'These are our shortcomings. Now let's get past it'."
Referring to Cruise, Clooney said: "I talked to him the other day, and he's a good egg. There's nothing self-serving about what he's saying. He has to turn it into a way to make fun of himself."
Clooney made the comments in an interview with Time, saying that he isn't afraid to mock himself.
The actor said: "Before they could kill me on 'Batman & Robin', I said: 'It's a bad film, and I'm the worst thing in it.' You try to defend an indefensible position, you'll look like a schmuck."
"The guys I dig don't do that. Look at Winston Churchill. He said: 'These are our shortcomings. Now let's get past it'."
Referring to Cruise, Clooney said: "I talked to him the other day, and he's a good egg. There's nothing self-serving about what he's saying. He has to turn it into a way to make fun of himself."
Monday, 2 June 2008
Hidden Skills
Artist: Hidden Skills
Genre(s):
Drum & Bass
Discography:
Indifferent CDS
Year: 2004
Tracks: 1
Bruce Robison
Heather Mills to star in Celebrity Apprentice?
Heather Mills is reportedly set to star in Donald Trump’s Celebrity Apprentice.
The former porn star, 40, will go head-to-head with several US celebrities in the NBC show.
Paul McCartney’s ex-wife met Trump when she was a judge on a Miss USA beauty pageant, where she got booed and jeered by the crowd.
See Also
Filo and Peri Feat Eric Lumiere
Artist: Filo and Peri Feat Eric Lumiere
Genre(s):
Trance
Discography:
Anthem (Incl Nic Chagall Remix)
Year: 2007
Tracks: 3
Bands reduce carbon footprints - but their fans' cars pollute
Stephen Sondheim
Artist: Stephen Sondheim
Genre(s):
Other
Discography:
Into the Woods
Year: 2002
Tracks: 18
According to most critics and dramaturgy historians, Stephen Sondheim (born 1930) stands among Broadway render composers and lyricists not only as the superlative of his generation only as the only when great 1 of his generation. There may be many reasons wherefore Broadway failed to give rise systematically great writers to espouse the Rodgers & Hammersteins and Lerner & Loewes of the '40s and '50s, but the fact remains that though he operates without serious competition, Sondheim clearly ranks with such edgar Lee Masters, as well as with the Jerome Kerns and Irving Berlins of an even sooner generation.
Sondheim became a protégé of Hammerstein's afterwards befriending the lyricist's son in schooling, just he got his number one bragging break when he was hired to save lyrics to Leonard Bernstein's score for West Side Story (1957), which turned out to be one of the biggest hits and about memorable whole kit and boodle of its clip. This light-emitting diode to a tidy sum of lyric-writing exercise, though Sondheim always wanted to write music as intimately. Nevertheless, he worked with Jule Styne on Gypsy (1959), another enormous strike, and would later agree to do the same with Richard Rodgers for the unsuccessful Do I Hear a Waltz? (1965).
Earlier that, nonetheless, Sondheim scored his first success as composer and lyricist with A Funny Thing Happened on the Way to the Forum (1962). It was his final murder until Company (1970), a render around contemporary life and mores that did very much to revolutionize the Broadway musical and, as Hammerstein's '50s shows had, run it more toward serious and alien subjects. Since that time, Sondheim's shows have been surprisingly daring in footing of field of study matter, with unusual musical ideas and stunningly original lyrics. But they have not always been big hits and have pronounced a clip in dramatic art when Broadway render music became a marginalized fine art form in terms of popular culture.
Yet, Sondheim's shows of the '70s and '80s are benchmarks of the genre: Follies (1971) brought together aging follies girls for a look at middle-aged American life; A Little Night Music (1973) is based on Ingmar Bergman's film Smiles of a Summer Night and contains Sondheim's sole murder strain, "Send in the Clowns"; Pacific Overtures (1976) ambitiously took on the subject of Japanese-American relations; Sweeney Todd (1979) was an operetta based on the British lofty guignol narrative of a murderous barber; Sunday in the Park with George (1984) was a life story of impressionist painter Georges Seurat; and Into the Woods (1987) wove together children's fairy tales with the theories of psychologist Bruno Bettelheim. In 1991, Sondheim wrote his first off-Broadway musical, Assassins, a short piece around presidential killers. He as well turned more than to films (he had scripted a score for Stavisky in the '70s), writing songs for Madonna in Hawkshaw Tracy in 1990 and functional on an original moving picture musical. But his future work to seem was a Broadway melodious, Passion, in 1994. He was occupied in the 1990s educational activity and overseeing various productions of his existing work, simply he also prepared a new melodic, which, after many delays and claim changes, was scheduled to be staged in 2003 under the name Bounce.
Soundflavor Video Jukebox Plays Music Videos That You Like
New website and widget from Soundflavor makes music video playlists for
Facebook, MySpace, blogs, other websites based on your tastes in music
SAN FRANCISCO, May 28 -- Soundflavor has launched a new
music video discovery website and "Video Jukebox" widget to enable anyone
to quickly make and share music video playlists. Visitors create video
playlists by uploading their iTunes playlists or by using Soundflavor's
powerful music search and recommendation features. They can then use the
Soundflavor Video Jukebox to play and share their video playlists on
popular social networking sites, blogs and other websites.
Unlike other websites that offer music videos, Soundflavor.com allows
music fans to make "one-click" video playlists based on the "sound" of any
song or artist that they like.
Visitors can also browse music videos by "flavor" according to
subgenre, tempo, year, lyrical content, mood, instruments and similarity to
other artists or songs. The website's "Flavor Filters" make it easy to find
videos by combining flavors -- for example, singer/songwriter tunes from
the 1970's that mourn a bad breakup.
Soundflavor.com and the Soundflavor Video Jukebox are the latest
products to be built using the company's Advanced Music Search platform.
Over the past six years, the company has analyzed nearly one million songs,
and created a database of deep musical "attributes" describing each song,
such as musical density, subject matter and key instruments. The platform's
various search, discovery, and recommendation features center on this
database, and have been extensively tuned through years of live testing by
both music consumers and industry professionals.
Soundflavor also announced that it is offering its Advanced Music
Search platform to companies that sell, stream, or license music, or
provide social networking around music. Through a variety of licensing
options, Soundflavor can enable users of third party music websites to
browse, discover, play, and purchase more music.
"Soundflavor's Advanced Music Search platform was built to help music
fans and pros spend less time scratching their heads, and more time
discovering and enjoying music that they care about," said Steve
Skrzyniarz, CEO of Soundflavor. "With millions of music videos available
online, viewers face the classic problem of too much choice. Solving this
dilemma is another great application for our platform, and we are excited
to be rolling out the new website and Video Jukebox."
About Soundflavor, Inc.
Soundflavor, Inc. provides industry-leading advanced music search and
discovery products to companies that sell or license music, or provide
social networking around music. The company's Advanced Music Search
platform is available for licensing to enable consumer and commercial music
companies to enable their users to find, discover, sample and purchase
music more efficiently. Its platform centers on a large database of deep
information about individual songs, spanning nearly one million individual
tracks.
Soundflavor is based in San Francisco. For more information, see
http://www.soundflavor.com
See Also
Facebook, MySpace, blogs, other websites based on your tastes in music
SAN FRANCISCO, May 28 -- Soundflavor has launched a new
music video discovery website and "Video Jukebox" widget to enable anyone
to quickly make and share music video playlists. Visitors create video
playlists by uploading their iTunes playlists or by using Soundflavor's
powerful music search and recommendation features. They can then use the
Soundflavor Video Jukebox to play and share their video playlists on
popular social networking sites, blogs and other websites.
Unlike other websites that offer music videos, Soundflavor.com allows
music fans to make "one-click" video playlists based on the "sound" of any
song or artist that they like.
Visitors can also browse music videos by "flavor" according to
subgenre, tempo, year, lyrical content, mood, instruments and similarity to
other artists or songs. The website's "Flavor Filters" make it easy to find
videos by combining flavors -- for example, singer/songwriter tunes from
the 1970's that mourn a bad breakup.
Soundflavor.com and the Soundflavor Video Jukebox are the latest
products to be built using the company's Advanced Music Search platform.
Over the past six years, the company has analyzed nearly one million songs,
and created a database of deep musical "attributes" describing each song,
such as musical density, subject matter and key instruments. The platform's
various search, discovery, and recommendation features center on this
database, and have been extensively tuned through years of live testing by
both music consumers and industry professionals.
Soundflavor also announced that it is offering its Advanced Music
Search platform to companies that sell, stream, or license music, or
provide social networking around music. Through a variety of licensing
options, Soundflavor can enable users of third party music websites to
browse, discover, play, and purchase more music.
"Soundflavor's Advanced Music Search platform was built to help music
fans and pros spend less time scratching their heads, and more time
discovering and enjoying music that they care about," said Steve
Skrzyniarz, CEO of Soundflavor. "With millions of music videos available
online, viewers face the classic problem of too much choice. Solving this
dilemma is another great application for our platform, and we are excited
to be rolling out the new website and Video Jukebox."
About Soundflavor, Inc.
Soundflavor, Inc. provides industry-leading advanced music search and
discovery products to companies that sell or license music, or provide
social networking around music. The company's Advanced Music Search
platform is available for licensing to enable consumer and commercial music
companies to enable their users to find, discover, sample and purchase
music more efficiently. Its platform centers on a large database of deep
information about individual songs, spanning nearly one million individual
tracks.
Soundflavor is based in San Francisco. For more information, see
http://www.soundflavor.com
See Also
- Music Impresario and Long-Time Humanitarian Quincy Jones Comments Publicly About China and the Darfur Crisis and His Role as an Artistic Advisor to the Opening Ceremonies of the 2008 Beijing Olympic Games
- Desperate Housewives - Housewives Audience Slow To Return
- Simpson And Wentz Marry In Fairy Tale Wedding
- CSS add North American dates to summer jaunt
Co-star gave Pitt marriage insight
Actor and comedian Omid Djalili, who met Brad Pitt on the set of 'Spy Game' in 2000, claims that he gave the actor marriage advice after he married Jennifer Aniston.
The comic star revealed to the Daily Express newspaper: "I did a scene with Brad in the back of a taxi and it was only a few days after he had married Jennifer. I chatted to him for hours giving him advice about the three stages of marriage."
He continued: "Stage one is perfection - blind love. Stage two is the difficult stage because you start to despise everything about her. If you can deal with the baggage you can possibly get to stage three - a harmonious marriage."
Pitt and Aniston were married in July 2000 in Malibu and Djalili told the newspaper: "After six weeks Brad came up to me and said, 'I'm definitely in stage two Omid!'"
Rumours of marital problems surfaced in 2004 as Pitt filmed 'Mr and Mrs Smith' alongside Angelina Jolie.
Aniston, 39, filed for divorce in March 2005. A month later, Pitt, 44, was seen with Jolie in Kenya. Earlier this week it was claimed the couple are planning to marry in an intimate ceremony this summer.
The comic star revealed to the Daily Express newspaper: "I did a scene with Brad in the back of a taxi and it was only a few days after he had married Jennifer. I chatted to him for hours giving him advice about the three stages of marriage."
He continued: "Stage one is perfection - blind love. Stage two is the difficult stage because you start to despise everything about her. If you can deal with the baggage you can possibly get to stage three - a harmonious marriage."
Pitt and Aniston were married in July 2000 in Malibu and Djalili told the newspaper: "After six weeks Brad came up to me and said, 'I'm definitely in stage two Omid!'"
Rumours of marital problems surfaced in 2004 as Pitt filmed 'Mr and Mrs Smith' alongside Angelina Jolie.
Aniston, 39, filed for divorce in March 2005. A month later, Pitt, 44, was seen with Jolie in Kenya. Earlier this week it was claimed the couple are planning to marry in an intimate ceremony this summer.
Eastenders' Tanya to bury Max alive?
'EastEnders' character Tanya Branning will bury cheating husband Max alive in a sensational storyline, according to reports.
The mum of three, played by actress Jo Joyner, takes revenge for his affair with his daughter-in-law, Stacey Slater (Lacey Turner).
After weeks of plotting, Tanya seduces Max (Jake Wood) and then drugs him before putting him in a coffin and burying it in woods, according to The Sun newspaper.
The scenes are due to be shown at Easter.
The Sun quotes a BBC source as saying: "Viewers will have to wait to find out whether Max lives or dies."
Max and Tanya's relationship becomes increasingly more volatile as they battle over custody of their children.
The mum of three, played by actress Jo Joyner, takes revenge for his affair with his daughter-in-law, Stacey Slater (Lacey Turner).
After weeks of plotting, Tanya seduces Max (Jake Wood) and then drugs him before putting him in a coffin and burying it in woods, according to The Sun newspaper.
The scenes are due to be shown at Easter.
The Sun quotes a BBC source as saying: "Viewers will have to wait to find out whether Max lives or dies."
Max and Tanya's relationship becomes increasingly more volatile as they battle over custody of their children.
Subscribe to:
Posts (Atom)